Plné znění - 2/2008 Sb. m. s.

Xxxxxxxxxxxx xxxxxxxxxxxx xxxx xxxxxxx, xx xxx 16. listopadu 2007 xxxx generálním xxxxxxxxx UNESCO, depozitářem Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx ve sportu¹⁾, xxxxxxxx xxxxxxxxx xxxxxx xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx xxxxx x xxxxx dopingu.

Xxxxxxx X xxxxxxxxx x xxxxxxxx x xxxxxxx s článkem 34 xxxx. 3 Xxxxxx xxx 1. xxxxx 2008 x xxxxx xxxx xxxxxxxxx x xxxxxxxx x xxx Xxxxxx republiku. Xxxx xxxxxx Xxxxxxx X x xxxxxxxx xxxxxxxx xxxxxx Xxxxxxx X Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx xx znění xxx xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. x. s.

Xxxxxxxx xxxxx Xxxxxxx X x xxxx xxxxxxx xx českého xxxxxx xx xxxxxxxxx xxxxxxxx.

X1. XXXXXXXXXX LÁTKY

Xxxxxxxxxx xxxxx jsou xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX STEROIDY (XXX):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-androstendiol (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-xxxxxxxxxxxxx (5α-androst-1-en-3,17-dion); xxxxxxxxx (19-norandrostendiol); xxxxxxxxxx; xxxxxxxx; xxxxxxx (androsta-1,4-dien-3,17-dion); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxx-5α-xxxxxxx-2-xx-17β-xx); xxxxxxxxxxx; ethylestrenol (19-nor-17α-pregn-4-en-17-ol); xxxxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); xxxxxxxxx; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); kalusteron; klostebol; xxxxxxxxxx; mesterolon; xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; methandriol; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); methylnortestosteron (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx); xxxxxxxxxxxxxxxxx; xxxxxxxxx; nandrolon; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; xxxxxxxxxxxxxx; xxxxxxxxxxxx; xxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; stanozolol; xxxxxxxxx; 1-xxxxxxxxxxx (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (18α-homo-pregna-4,9,11-trien-17β-ol-3-on); xxxxxxxxx x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx účinky.

x. Xxxxxxxxx ** AAS:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), dihydrotestosteron, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX), xxxxxxxxxxx x xxxxxxxxxxx xxxxxxxxxx x xxxxxxx:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)

5α-androstan-3β,17α-diol 5-androstendion (xxxxxxx-5-xx-3,17-xxxx)

5α-androstan-3β,17β-diol epi-dihydrotestosteron

androst-4-en-3α,17α-diol 3α-hydroxy-5αandrostan-17-on

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

androst-5-en-3α,17α-diol 19-noretiocholanolon

androst-5-en-3α,17β-diol

X xxxxxxxxx, xxx xxxx xxxx produkovat xxxxxxxxxx xxxxxxxxxx steroid xxxxxxxxx, xxxx xx xxx xx xx, xx Xxxxxx obsahuje tuto Xxxxxxxxx látku x xxxx xxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxx xx koncentrace Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxxx x/xxxx xxxx xx xxxxxxxx xxxx xxxxxxxxx xxxxx xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxx od xxxxxxx xxxxxx, které xx xxxxxxxx vyskytují u xxxx xxx, xx xxxxxxxxxx normální xxxxxxxxx xxxxxxxx. Xxxxxx xx xxx za xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx v xxxxxxx případě, xxxxx Xxxxxxxxx xxxxxxx, že xx koncentrace Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx příslušný poměr xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxxxxxx xxxx xxxxxxxxxxxx xxxxxx.

Xxxx xx mít za xx, že Vzorek Xxxxxxxxx xxxxxxxx Zakázanou xxxxx x laboratoř xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx xx všech xxxxxxxxx a xxx xxxxxxxxx xxxxxxxxxxx, xxxxx xxx xxxxx spolehlivé xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx, xx xx Zakázaná xxxxx xxxxxxxxxx původu. X xxxxxxx xxxxxxx xxxx xxxxx provádět další xxxxxxx.

Xxxx xx xxxxxxx xxxxxxxx analýzy xxxxxxxx xxxxxxxxxxx od xxxxxxx xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx x lidí x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx původ Xxxxxxxx látky, ale xxxxxxxx xxxxxx xxxxxxx Xxxxxxxx látky, jako xxxx. xxxxxxxxx x xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx xxxxxxx, nebo když xxxxxxxxx xxxxxxxxx xxxxx X/X xxxxx xxx xxxxx (4) ku xxxxx (1) a xxxxx spolehlivá xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxxxxx xxxxxxxx původ xxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx organizace xxxxx xxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxxxxxx následných testů.

Xx-xx vyžadováno takové xxxxx xxxxxxx, pak xxxxxxxx xxxx xxxxxxxxxx xxxxxx xxxx xxxxxxxxx x xx jako xxxxxxxxx. Pokud xxxxxxxxx xxxxxxx, xx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxxx nutné xxxxxxxx xxxxx xxxxxxx, x xxxx xx xxx xx xx, že Xxxxxx obsahuje Xxxxxxxxx xxxxx. Xxxxx nebyla xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) x nejsou x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx testy, bude xxxxxxx xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx xxx, že xxxx xxxxxxxxxx Xxxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxx 3 měsících xxxxxxx xxxxxxxx xxx xxxxxxxxxxx xxxxxxxx. Výsledek, xxxxx xxxxxxxxxx tuto xxxxxxxxxxxxxx xxxxxx, xxxx xxxxxx xxxx neobvyklý. Xxxxx xxxxxxxxxxxxxx profil Sportovce, xxxxxxxx xxxxxxxxxx xxxxx, xxxx fyziologicky xxxxxxxx, xxxx xx xxx xxxxxxxxx za Pozitivní xxxxxxxxxxx xxxxx.

X xxxxxxxx vzácných xxxxxxxxxxxxxx xxxxxxxxx může být x xxxx trvale xxxxxxx xxxxxxxx endogenního xxxxxx xx xxxxxx xxxxxx koncentracích (ng/ml). Xxxxx xxxxxxxxx xxxxxx xxxxx nahlásila a xxxxxxx xxxxxxxxxx analytické xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx látky, může xxx xxxxxxxxx další xxxxxxx provedením xxxxxxxxxx xxxxx (následných xxxxx).

Xxxxx xxxxxxxxx xxxxxxxxx Xxxxxxxxx laboratorní xxxxx 19-xxxxxxxxxxxxxxx, xxxx xx xx xxxxxxxxx za xxxxxxx a xxxxxxxxxxx xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx xxxxx. X xxxxxxx případě xxxx xxxxx xxxxxxxx další xxxxxxx.

X případě, xx Xxxxxxxxx xxxxxx xxxxxxxxxxxxx xxx dalších xxxxxxxxx, xxxx xx xxx xx xx, xx Vzorek Xxxxxxxxx xxxxxxxx Zakázanou látku.

2. Xxxxxxx xxxxxxxxxx xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX), tibolon, xxxxxxx, xxxxxxxxxx, ale xx s omezením xxxxx na xx.

X2. XXXXXXX X XXXXXXXX XXXXX

Xxxxxxxxxxx xxxxx x xxxxxx uvolňující xxxxxxx xxxx zakázány:

1. Xxxxxxxxxxxx (XXX);

2. Xxxxxxx xxxxxx (xXX), insulinu xxxxxxx xxxxxxx faktory (např. XXX-1), xxxxxxxxxx xxxxxxx xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (xxxx. LH, xXX), xxxxxxxx xxx x mužů;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x xxxxx látky x podobnou xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxx Xxxxxxxxx xxxxxx xxxxxxxx, xx xxxxxxxxxxx xxxx xxxxxxxxx fyziologickým xx xxxxxxxxxxxx stavem, xxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx látku (xxx xx xxxxxxx xxxx) x xxxxxxxxx, xxx xxxxxxxxxxx Zakázané xxxxx xxxx xxxxxx xxxxxxxxxx xx indikátorů x/xxxx xxxxxxxxx poměry xx Vzorku Xxxxxxxxx xxxxxxx xxxxxxxx hodnoty xxxxxxxx xxxxxxxx x xxxx xxx, xx xxxxxxxxxxxx xxxxxxxx endogenní xxxxxxxx.

Pokud laboratoř xxxxxxxxx, xx xxxxx xxxxxxxxxx analytické xxxxxx, xx Xxxxxxxx xxxxx xx xxxxxxxxxx xxxxxx, xxxx xx xxx xx xx, že Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx a xxxx xxxxxxx Xxxxxxxxx laboratorní xxxxx.

X3. XXXX-2 XXXXXXXX

Všichni xxxx-2 xxxxxxxx xxxxxx xxxxxx X- x X-xxxxxxx jsou xxxxxxxx.

Xxxxxxxx xxxx xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxxx, pro xxxxx xx xxx xxxxxxxx xxxxx xxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxxx.

I xxxx xxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxx, xxxx xxxxx xxxxxxxxxxx (volný xxxx xxxxxxxxxx) vyšší xxx 1000 xxxxxxxxx v 1 mililitru moči xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx nález, xxxxx Xxxxxxxxx xxxxxxxxx, že xxxxxxxxxx výsledek xxx xxxxxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxx x xxxxxxxx.

S4. XXXXXXXXXXX X MODULÁTORY XXXXXXX

Xxxxxxxxxxx skupiny xxxx xxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

2. Xxxxxxxxxx modulátory xxxxxxxxxxxxx xxxxxxxxx (SERM), xxxxxxxx:

3. Xxxxxxx antiestrogenní xxxxx xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx funkce xxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, ale xx x xxxxxxxx pouze xx ně.

X5. DIURETIKA X XXXXXXX MASKOVACÍ LÁTKY

Maskovací xxxxx xxxx xxxxxxxx. Zahrnují:

Xxxxxxxxx*, xxxxxxxxxxxxxx, probenecid, xxxxxxxxxx xxxx-xxxxxxxxx (xxxx. xxxxxxxxxx, xxxxxxxxxx), xxxxxxxxxxxxxxx (xxxx. albumin, dextran, xxxxxxxxxxxxxxxxx) x další xxxxx s podobnými xxxxxxxxxxxx xxxxxx.

Xxxxxxxxx xxxxxxxx:

Acetazolamid, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, kanrenon, kyselina xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), triamteren x další látky x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx (kromě xxxxxxxxxxxx, který xxxx xxxxxxxx).

* Terapeutická xxxxxxx xxxx xxxxxx, xxxxx xxx Sportovce xxxxxxxx xxxxxxxxx xx xxxxxxx x xxxxxxxx xxxx podprahovou hladinou xxxx Zakázané látky (xxxxx).

X1. XXXXXXXXX XXXXXXX XXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

X2. XXXXXXXX X FYZIKÁLNÍ XXXXXXXXXX

X3. XXXXXX DOPING

Neterapeutické xxxxxxx xxxxx, genů, xxxxxxxx xxxxxxxx, nebo xxxxxxxxxx xxxxxxx xxxx, xxxxx mají xxxxxxxxx xxxxxx xxxxxxxxx výkon, xx xxxxxxxx.

X6. STIMULANCIA

Xxxxxxx xxxxxxxxxxx (včetně obou xxxxxx xxxxxxxxxx optických (X- a X-) xxxxxxx) xxxx xxxxxxxx, x xxxxxxxx derivátů xxxxxxxxx x případě xxxxxx xxxxxxxx xxxxx x stimulancií xxxxxxxxxx xx Xxxxxxxxxxxxxx xxxxxxxx xxx xxx 2008.

Xxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx, xxxxxxxxx**, xxxxxxxxxx, amfetaminil, xxxxxxxxxx, xxxxxxxxx, benzfetamin, xxxxxxxxxxxxxxx, bromantan, cyklazodon, xxxxxxxxxxxxxxxxx, xxxxxxx****, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, famprofazon, xxxxxxxxxxx, xxxxxxxxxxxxx, fenetylin, xxxxxxxxxxx, xxxxxxxxxxx, fenkamin, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, 4-fenylpiracetam (karfedon), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxx***, klobenzorex, xxxxxx, xxxxxxxxxxx, xxxxxxxxxx, levmetamfetamin, xxxxxxxxx, mefentermin, xxxxxxxxxxxx, xxxxxxxxxxxx (D-), metylefedrin****, xxxxxxxxxxxxxxxxxxxxxx, methylendioxymetamfetamin, xxxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxx, oktopamin, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxxxxxxxx, xxxxxxx, xxxxxxxxxxx, x-xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, selegilin, xxxxxxxxxx, xxxxxxxxx, tuaminoheptan x xxxxx látky x xxxxxxxx chemickou xxxxxxxxxx nebo podobnými xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx xxxxxxxx xxxx xxxxxxxx v xxxxx xxxxxx xxxx xxxxxxxxxx za specifickou xxxxx xxxxx, xxxxx Xxxxxxxxx prokáže, že xxxx xxxxxxxxx xxxxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxx je x xxx menší xxxxxxxxxxxxxxx, xx bude úspěšně xxxxxxxx xxxx dopingová xxxxx.

X7. XXXXXXXXX

Následující narkotika xxxx xxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), xxxxxxxx x xxxx deriváty, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, oxymorfon, pentazocin, xxxxxxx.

X8. XXXXXXXXXXX

Xxxxxxxxxxx (xxxx. xxxxx, marihuana) xxxx xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx glukokortikosteroidy xxxxxxxx xxxxxx, rektálně, xxxxxxxxxx nebo xxxxxxxxxxxxx xxxxxxxx xxxx xxxxxxxx. Xxxxxx užití vyžaduje xxxxxxxxxxxxx xxxxxxx.

Jiné xxxxxxx xxxxxxxx aplikace (xxxxxxxxxxxx, xx xxxxx xxxxxx, xx xxxxx xxxxxx, xxxxxxxxxx, do xxxx) x inhalační xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxxx níže uvedených.

Xxxxxxx přípravky xxxxxxxx xx xxxxxx xxxxx (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), xxxx, xxxxx, xxxx, xxxxxx xxxxx xxxxxxx xxxxxx, xxxxxxxx xxx a xxxxx nejsou zakázané x nevyžadují xxxxxx xxxxx xxxxxxxxxxxx výjimky.

P1. XXXXXXX

Xxxxxxx (etanol) xx xxxxxxxx pouze Xxx xxxxxxx x xxxxxxxxxxxxx xxxxxxxx. Detekce xx xxxx xxxxxxxx xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx xxxx. Prahová xxxxxxx pro xxxxxxxx xxxxxxxxxxx xxxxxxxx (xxxxxxxxxxxxx xxxxxxx) xx xxx xxxxxx xxxxxxxx xxxxxxx x závorkách.

∙ Xxxxxxxxxxxx sport (XXX) (0.10 x/x)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxx a xxxxxxxxxxxx (XXX) (0.20 x/x)

∙ Xxxxxxxxxxx (XXXX, XXX) (0.10 g/l)

∙ Xxxxxxx pětiboj (XXXX) xxx pro xxxxxxxxxx xx xxxxxxxx (0.10 x/x)

∙ Motocyklový xxxxx (XXX) (0.10 g/l)

∙ Xxxxx motorismus (XXX) (0.30 g/l)

∙ Kuželky (IPC) (0.10 x/x)

X2. BETA-BLOKÁTORY

Pokud xxxx xxxxx xxxxxx, xxxx-xxxxxxxxx jsou zakázány xxxxx Xxx soutěži x xxxxxxxxxxxxx sportech.

∙ Xxxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx (XXXX)

∙ Boby (XXXX)

∙ Xxxxx (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Xxxxxxxx (XXXX) - "xxxxx xxxx" - jen xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Xxxxxxx xxxxxx x xxxxxxxxxxxx (XXX)

∙ Xxxxxxxxxxx (XXXX, XXX) (xxxxxxxx xxxx Xxxx xxxxxx)

∙ Xxxxxxxx (XXX) - xxxxx xx xxxxxx x xxxxxxxxxxx xxxxxxxx-xxxxx x X-xxxxx, x xxxxxxxxx X-xxxxx x "xxx xxx"

∙ Moderní xxxxxxx (XXXX) - jen xxxxxxxxxx se xxxxxxxx

∙ Xxxxxxxxxxx sport (XXX)

∙ Xxxxxxxx x obdobné xxxxxx (XXXX, XXX "xxxxx")

∙ Střelba (XXXX, XXX) (xxxxxxxx také Xxxx xxxxxx)

∙ Xxxxx xxxxxxxxxx (UIM)

∙ Zápas (FILA)

Xxxx-xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx:

Xxxxxxxxxx, alprenolol, xxxxxxxx, betaxolol, bisoprolol, xxxxxxx, celiprolol, xxxxxxx, xxxxxxxxx, karvedilol, labetalol, xxxxxxxxxxx, xxxxxxxxxxxx, metoprolol, xxxxxxx, oxprenolol, xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxxx, xxx ne s xxxxxxxx pouze xx xx

"Xxxxxxxxxx xxxxx"* xxxx vyjmenovány níže:

∙ Xxxxxxx Xxxx-2 xxxxxxxx v inhalaci, xxxxx xxxxxxxxxxx (xxxxxxx xxxx glukuronidu) xxx xxxxxxxx xxxxxx xxx 1000 ng/ml moči x xxxxxxxxxxxx (xxxxxxx xx skupině X 1.2 Xxxxxxx anabolické xxxxx);

∙ Inhibitory xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, xxxxxxxxxxx, krotetamid, xxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, p-metylamfetamin, xxxxxxxxxxxx, xxxxxxxxx, norfenefrin, xxxxxxxxx, xxxxxxxxx, oxilofrin, xxxxxxxxxxxxxx, xxxxxxxxx, sibutramin, xxxxxxxxxxxxx x xxxxxxx xxxxxxx xxxxxxxxxxx neuvedená xxxxxxxx v xxxxxx X6, pro xxxxx Xxxxxxxxx prokáže, xx xxxxxxx xxxxxxxx xxxxxxx x xxxxxx S6;

∙ Xxxxxxxxxxx;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"V Xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxxxxxxx xxxxx, xxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx jsou všeobecně xxxxxxxx x xxxxxxx xxxxxxxxx přípravcích, xxxx x nichž xx xxxxx pravděpodobnost, xx xxxxx úspěšně zneužity xxxx dopingová xxxxxxx." Xxxxxxxx antidopingového xxxxxxxx xxxxxxxxxx takovéto látky xxxx xxxxxxxx xxxxxxx xxxxxx xx xxxxxxxxxxx, xx "...Xxxxxxxxx může xxxxx xxxxxxxx, xx Xxxxxxx specifické xxxxx xxxxxx xxxxxxxxx xx xxxxxxx xxxxxxxxxxx výkonu...".

Xxxxxx předpis x. 2/2008 Xx. x. x. nabyl účinnosti xxxx 31.1.2008.

Xxxxxx xxxxxxx x. 2/2008 Xx. x. x. xxx xxxxxx xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x účinností xx 7.2.2009.

Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, pokud xx xxxx xxxxxx xxxxxxxxx xxxxx shora xxxxxxxxx xxxxxxxx xxxxxxxx.